Regulatory Considerations for Approval of Generic Inhalation Drug Products in the US, EU, Brazil, China, and India.
about
Batch-to-batch pharmacokinetic variability confounds current bioequivalence regulations: A dry powder inhaler randomized clinical trialThe long and winding road to inhaled TB therapy: not only the bug's fault.Bioequivalence Evaluations of Generic Dry Powder Inhaler Drug Products: Similarities and Differences Between Japan, USA, and the European Union.Inhalation devices: from basic science to practical use, innovative vs generic products.Scientific Rationale for Determining the Bioequivalence of Inhaled Drugs.Current Scientific and Regulatory Approaches for Development of Orally Inhaled and Nasal Drug Products: Overview of the IPAC-RS/University of Florida Orlando Inhalation Conference.Randomized, Double-Blind, Crossover, Clinical-End-Point Pilot Study to Examine the Use of Exhaled Nitric Oxide as a Bioassay for Dose Separation of Inhaled Fluticasone Propionate.
P2860
Q37404474-E4EC32A3-3EA5-484C-A259-13C6405DE401Q38782463-9109E5D2-B4CF-411E-AC61-A59DC1763DACQ38837545-59DA6677-461B-4799-8358-86AA89C97079Q38856654-81E0F3EF-6142-4C08-8A38-52EBB644DF49Q38909886-A2438105-C665-4BC8-8F8D-C547596DBAA2Q42590354-FB718AAA-BEDB-4592-8093-8FA9624A2AA3Q49380807-7E06F14E-EDF4-42AC-8035-A336D6D7A657
P2860
Regulatory Considerations for Approval of Generic Inhalation Drug Products in the US, EU, Brazil, China, and India.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Regulatory Considerations for ...... EU, Brazil, China, and India.
@ast
Regulatory Considerations for ...... EU, Brazil, China, and India.
@en
type
label
Regulatory Considerations for ...... EU, Brazil, China, and India.
@ast
Regulatory Considerations for ...... EU, Brazil, China, and India.
@en
prefLabel
Regulatory Considerations for ...... EU, Brazil, China, and India.
@ast
Regulatory Considerations for ...... EU, Brazil, China, and India.
@en
P2093
P2860
P1433
P1476
Regulatory Considerations for ...... EU, Brazil, China, and India.
@en
P2093
Abhijit Vaidya
Alfredo García-Arieta
Bhawana Saluja
Gustavo Mendes Lima Santos
Jaideep Gogtay
Juliet Rebello
Shrinivas Purandare
Shuguang Hou
P2860
P2888
P304
P356
10.1208/S12248-015-9787-8
P407
P577
2015-05-23T00:00:00Z
P6179
1029556240